1. N6-Methyladenosine (m6A) Depletion Regulates Pluripotency Exit by Activating Signaling Pathways in Embryonic Stem Cells”. Jin K, Zuo H, Klungland A, Anastassiadis K, Marr C & Filipczyk A. PNAS. 2021 In Press. (Impact Factor: 12.3)
  2. Reversible RNA modifications in meiosis and pluripotency. Klungland A, Dahl JA, Greggains G, Fedorcsak P, Filipczyk A. Nat Methods. 2016 29;14(1):18-22. (Impact Factor: 25). (2 citations).
  3. Analysis of Cell Lineage Trees by Exact Bayesian Inference Identifies Negative Autoregulation of Nanog in Mouse Embryonic Stem Cells. Feigelman J, Ganscha S, Hastreiter S, Schwarzfischer M, Filipczyk A, Schroeder T, Theis FJ, Marr C, Claassen M. Cell Systems. 2016 Nov 23;3(5):480-490. (Impact Factor: 8) (5 citations).
  4. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Hoppe PS, Schwarzfischer M, Loeffler D, Kokkaliaris KD, Hilsenbeck O, Moritz N, Endele M, Filipczyk A, Gambardella A, Ahmed N, Etzrodt M, Coutu DL, Rieger MA, Marr C, Strasser MK, Schauberger B, Burtscher I, Ermakova O, Bürger A, Lickert H, Nerlov C, Theis FJ, Schroeder T. Nature. 2016 Jul 14;535(7611):299-302. (Impact Factor: 42). (29 citations)
  5. Software tools for single-cell tracking and quantification of cellular and molecular properties. Hilsenbeck O, Schwarzfischer M, Skylaki S, Schauberger B, Hoppe PS, Loeffler D, Kokkaliaris KD, Hastreiter S, Skylaki E, Filipczyk A, Strasser M, Buggenthin F, Feigelman JS, Krumsiek J, van den Berg AJ, Endele M, Etzrodt M, Marr C, Theis FJ, Schroeder T. Nat Biotechnol. 2016 Jul 12;34(7):703-6. (Impact Factor: 39). (16 citations)
  6. Network plasticity of pluripotency transcription factors in embryonic stem cells. Filipczyk A, Marr C, Hastreiter S, Feigelman J, Schwarzfischer M, Hoppe PS, Loeffler D, Kokkaliaris KD, Endele M, Schauberger B, Hilsenbeck O, Skylaki S, Hasenauer J, Anastassiadis K, Theis FJ, Schroeder T. Nat. Cell. Biol. 2015 Oct;17(10):1235-46. (Impact Factor: 20). (49 citations)
  7. Biallelic expression of nanog protein in mouse embryonic stem cells. Filipczyk A, Gkatzis K, Fu J, Hoppe PS, Lickert H, Anastassiadis K, Schroeder T. Cell Stem Cell. 2013 Jul 3;13(1):12-3. (Impact Factor: 22). (69 citations)
  8. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk A, Halle S, Klump H, Schöler HR, Baum C, Schroeder T, Schambach A. Mol Ther. 2011 Apr;19(4):782-9. (Impact Factor: 6). (151 citations).
  9. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Filipczyk A, Laslett AL, Mummery C, Pera MF. Stem Cell Res. 2007 Oct;1(1):45-60. (Impact Factor: 4). (76 citations)
  10. Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Filipczyk A, Passier R, Rochat A, Mummery CL. Cell Mol Life Sci. 2007 Mar;64(6):704-18. (Impact Factor: 6). (56 citations)
  11. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Herszfeld D, Wolvetang E, Langton-Bunker E, Chung TL, Filipczyk A, Houssami S, Jamshidi P, Koh K, Laslett AL, Michalska A, Nguyen L, Reubinoff BE, Tellis I, Auerbach JM, Ording CJ, Looijenga LH, Pera MF. Nature Biotechnol. 2006 Mar;24(3):351-7. (Impact Factor: 39). (147 citations).


Page visits: 207